Circle Image 1

Established in 2013, Comradis® is a specialist healthcare communications and commercialization consultancy that works exclusively on rare diseases, uncommon cancers and orphan drugs

We focus on
people, not statistics

Our goal is to understand the needs of the rare disease community and look beyond the data to provide meaningful content

We take a
collaborative approach

To secure a better future for families affected by rare diseases and uncommon cancers, we develop partnerships with pharmaceutical and biotechnology clients, patients, caregivers, advocates and clinicians

Circle Image 2
What We Do

With experience working across more than 50 rare diseases, we are highly skilled in delivering clear and compelling healthcare communications in this complex and unique area, including:

Congresses and educational meetings

Scientific communication platforms and messaging development

Publication planning and delivery

Patient engagement activities

Omni- and multichannel strategies, digital tools and resources

Advisory boards and insights gathering

Internal training activities

Medical and clinical trial educational resources


We provide objective analysis and creative programmes to make
novel treatments available earlier to more patients by:

Providing strategy planning and workshops

Identifying key experts and influencers

Understanding data gaps

Determining market size

Analysing reimbursement pathways and payer needs

Supporting product launch


We are active members of the rare disease community and understand the importance of collaboration between stakeholders to facilitate better outcomes for those living with rare diseases. To do this, we:

Participate in specialist rare disease congresses

Generate community-led publications

Contribute to community magazines

Collaborate with patient groups and charities

What We Say

As experts in our field, we want to share our knowledge to stimulate conversation and inform viewpoints. Our latest white papers can be accessed below

Sanfilippo Logo

We successfully collaborated with the Cure Sanfilippo Foundation and Sanfilippo Children's Foundation in publishing the first-ever global consensus clinical care guidelines for Sanfilippo syndrome (also known as mucopolysaccharidosis type III)

Establishing these clinical care guidelines means that anyone affected by Sanfilippo syndrome should receive the medical, rehabilitative and support care they need and deserve

A copy of the guidelines can be accessed here

Our Team

Comradis® is part of AMICULUM®, an independent family of specialist healthcare communications agencies with over 350 medical communications professionals in 13 locations worldwide

Our team includes rare disease consultants, gene therapy communications experts, and experienced healthcare and patient advocacy professionals

We collaborate closely with colleagues from the wider family of AMICULUM® agencies, drawing expertise from other specialist teams

Contact Us

To learn more about how we can help you communicate and commercialize treatments for rare diseases and uncommon cancers, please get in touch

Please rotate your device